Targeted Therapy for Non- Small Cell Lung Cancer First Line and Beyond

被引：2

作者：

Brea, Elliott ^{[1
]}

Rotow, Julia ^{[2
]}

机构：

[1] Dana Farber Canc Inst, Dept Med Oncol, SM353, 450 Brookline Ave, Boston, MA 02215 USA

[2] Dana Farber Canc Inst, 450 Brookline Ave,DA1240, Boston, MA 02215 USA

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 03期

关键词：

Non-small cell lung cancer; Oncogenes; Targeted therapy; Resistance; TYROSINE KINASE INHIBITORS; DABRAFENIB PLUS TRAMETINIB; UNCOMMON EGFR MUTATIONS; POSITIVE SOLID TUMORS; OPEN-LABEL; MOLECULAR-MECHANISMS; ACQUIRED-RESISTANCE; INTEGRATED ANALYSIS; ANTITUMOR-ACTIVITY; TREATMENT-NAIVE;

D O I：

10.1016/j.hoc.2023.02.009

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：575 / 594

页数：20

共 120 条

[1]

Aggarwal C, 2022, J CLIN ONCOL, V40

[2] Osimertinib Plus Durvalumab in Patients With EGFR-Mutated, Advanced NSCLC: A Phase 1b, Open-Label, Multicenter Trial [J].

Ahn, Myung-Ju ;

Cho, Byoung Chul ;

Ou, Xiaoling ;

Walding, Andrew ;

Dymond, Angela W. ;

Ren, Song ;

Cantarini, Mireille ;

Janne, Pasi A. .

JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (05) :718-723

[3] Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC [J].

Antonia, S. J. ;

Villegas, A. ;

Daniel, D. ;

Vicente, D. ;

Murakami, S. ;

Hui, R. ;

Kurata, T. ;

Chiappori, A. ;

Lee, K. H. ;

de Wit, M. ;

Cho, B. C. ;

Bourhaba, M. ;

Quantin, X. ;

Tokito, T. ;

Mekhail, T. ;

Planchard, D. ;

Kim, Y. -C. ;

Karapetis, C. S. ;

Hiret, S. ;

Ostoros, G. ;

Kubota, K. ;

Gray, J. E. ;

Paz-Ares, L. ;

Carpeno, J. de Castro ;

Faivre-Finn, C. ;

Reck, M. ;

Vansteenkiste, J. ;

Spigel, D. R. ;

Wadsworth, C. ;

Melillo, G. ;

Taboada, M. ;

Dennis, P. A. ;

Ozguroglu, M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (24) :2342-2350

[4] Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy [J].

Aredo, Jacqueline V. ;

Mambetsariev, Isa ;

Hellyer, Jessica A. ;

Amini, Arya ;

Neal, Joel W. ;

Padda, Sukhmani K. ;

McCoach, Caroline E. ;

Riess, Jonathan W. ;

Cabebe, Elwyn C. ;

Naidoo, Jarushka ;

Abuali, Tariq ;

Salgia, Ravi ;

Loo Jr, Billy W. ;

Diehn, Maximilian ;

Han, Summer S. ;

Wakelee, Heather A. .

JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (06) :1030-1041

[5] Acquired Resistance to KRASG12C Inhibition in Cancer [J].

Awad, M. M. ;

Liu, S. ;

Rybkin, I. I. ;

Arbour, K. C. ;

Dilly, J. ;

Zhu, V. W. ;

Johnson, M. L. ;

Heist, R. S. ;

Patil, T. ;

Riely, G. J. ;

Jacobson, J. O. ;

Yang, X. ;

Persky, N. S. ;

Root, D. E. ;

Lowder, K. E. ;

Feng, H. ;

Zhang, S. S. ;

Haigis, K. M. ;

Hung, Y. P. ;

Sholl, L. M. ;

Wolpin, B. M. ;

Wiese, J. ;

Christiansen, J. ;

Lee, J. ;

Schrock, A. B. ;

Lim, L. P. ;

Garg, K. ;

Li, M. ;

Engstrom, L. D. ;

Waters, L. ;

Lawson, J. D. ;

Olson, P. ;

Lito, P. ;

Ou, S. -H. I. ;

Christensen, J. G. ;

Janne, P. A. ;

Aguirre, A. J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (25) :2382-2393

[6] High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden [J].

Benayed, Ryma ;

Offin, Michael ;

Mullaney, Kerry ;

Sukhadia, Purvil ;

Rios, Kelly ;

Desmeules, Patrice ;

Ptashkin, Ryan ;

Won, Helen ;

Chang, Jason ;

Halpenny, Darragh ;

Schram, Alison M. ;

Rudin, Charles M. ;

Hyman, David M. ;

Arcila, Maria E. ;

Berger, Michael F. ;

Zehir, Ahmet ;

Kris, Mark G. ;

Drilon, Alexander ;

Ladanyi, Marc .

CLINICAL CANCER RESEARCH, 2019, 25 (15) :4712-4722

[7] Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer [J].

Borghaei, H. ;

Paz-Ares, L. ;

Horn, L. ;

Spigel, D. R. ;

Steins, M. ;

Ready, N. E. ;

Chow, L. Q. ;

Vokes, E. E. ;

Felip, E. ;

Holgado, E. ;

Barlesi, F. ;

Kohlhaeufl, M. ;

Arrieta, O. ;

Burgio, M. A. ;

Fayette, J. ;

Lena, H. ;

Poddubskaya, E. ;

Gerber, D. E. ;

Gettinger, S. N. ;

Rudin, C. M. ;

Rizvi, N. ;

Crino, L. ;

Blumenschein, G. R. ;

Antonia, S. J. ;

Dorange, C. ;

Harbison, C. T. ;

Finckenstein, F. Graf ;

Brahmer, J. R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (17) :1627-1639

[8] Disparities in Biomarker Testing and Clinical Trial Enrollment Among Patients With Lung, Breast, or Colorectal Cancers in the United States [J].

Bruno, Debora S. ;

Hess, Lisa M. ;

Li, Xiaohong ;

Su, Eric Wen ;

Patel, Monaliben .

JCO PRECISION ONCOLOGY, 2022, 6

[9] Brigatinib versus Crizotinib in ALK-Positive Non-Small-Cell Lung Cancer [J].

Camidge, D. R. ;

Kim, H. R. ;

Ahn, M. -J. ;

Yang, J. C. -H. ;

Han, J. -Y. ;

Lee, J. -S. ;

Hochmair, M. J. ;

Li, J. Y. -C. ;

Chang, G. -C. ;

Lee, K. H. ;

Gridelli, C. ;

Delmonte, A. ;

Garcia Campelo, R. ;

Kim, D. -W. ;

Bearz, A. ;

Griesinger, F. ;

Morabito, A. ;

Felip, E. ;

Califano, R. ;

Ghosh, S. ;

Spira, A. ;

Gettinger, S. N. ;

Tiseo, M. ;

Gupta, N. ;

Haney, J. ;

Kerstein, D. ;

Popat, S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (21) :2027-2039

[10] Brigatinib Versus Crizotinib in ALK Inhibitor-Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial [J].

Camidge, D. Ross ;

Kim, Hye Ryun ;

Ahn, Myung-Ju ;

Yang, James C. H. ;

Han, Ji-Youn ;

Hochmair, Maximilian J. ;

Lee, Ki Hyeong ;

Delmonte, Angelo ;

Campelo, Maria Rosario Garcia ;

Kim, Dong-Wan ;

Griesinger, Frank ;

Felip, Enriqueta ;

Califano, Raffaele ;

Spira, Alexander I. ;

Gettinger, Scott N. ;

Tiseo, Marcello ;

Lin, Huamao M. ;

Liu, Yuyin ;

Vranceanu, Florin ;

Niu, Huifeng ;

Zhang, Pingkuan ;

Popat, Sanjay .

JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (12) :2091-2108

← 1 2 3 4 5 6 7 8 9 10 →